Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Falkai

Showing results (11-20 of 756) with videos related to

Pageof 76
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 27, 2008
Limitations of current therapies: why do patients switch therapies?Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 26, 2022
[Power Factors and Success Probability in Psychiatry and Neurology]Peter Falkai
MMW Fortschritte Der Medizin|February 9, 2023
Peter Falkai
MMW Fortschritte Der Medizin|May 2, 2008
[Gambler--porn addict--computer freak. Were is the borderline to illness?]Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 24, 2023
[Diversity in Neurology and Psychiatry]Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 18, 2018
[Pioneering research developments in psychiatry]Peter Falkai
MMW Fortschritte Der Medizin|April 16, 2025
Peter Falkai
Biological Psychiatry|July 22, 2015
Erythropoietin as an Innovative Add-on Therapy for DepressionPeter Falkai, Andrea Schmitt
MMW Fortschritte Der Medizin|March 18, 2016
[Work on the stress axis brings relief. Helping the highly sensitive patient]Peter Falkai, Christine Starostzik
European Archives of Psychiatry and Clinical Neuroscience|May 18, 2023
Introduction for the follow-up of the Eighth International Kraepelin Symposium at LMU MunichSchaub Annette, Peter Falkai
Pageof 76

Showing results (11-20 of 756) with videos related to

Sort By:
Pageof 76
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 27, 2008
Limitations of current therapies: why do patients switch therapies?Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 26, 2022
[Power Factors and Success Probability in Psychiatry and Neurology]Peter Falkai
MMW Fortschritte Der Medizin|February 9, 2023
Peter Falkai
MMW Fortschritte Der Medizin|May 2, 2008
[Gambler--porn addict--computer freak. Were is the borderline to illness?]Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 24, 2023
[Diversity in Neurology and Psychiatry]Peter Falkai
Fortschritte Der Neurologie-Psychiatrie|January 18, 2018
[Pioneering research developments in psychiatry]Peter Falkai
MMW Fortschritte Der Medizin|April 16, 2025
Peter Falkai
Biological Psychiatry|July 22, 2015
Erythropoietin as an Innovative Add-on Therapy for DepressionPeter Falkai, Andrea Schmitt
MMW Fortschritte Der Medizin|March 18, 2016
[Work on the stress axis brings relief. Helping the highly sensitive patient]Peter Falkai, Christine Starostzik
European Archives of Psychiatry and Clinical Neuroscience|May 18, 2023
Introduction for the follow-up of the Eighth International Kraepelin Symposium at LMU MunichSchaub Annette, Peter Falkai
Pageof 76